Search research articles
Contact Us
Filters
Showing results (321-330 of 426) with videos related to
Page
of 43
Sort By:
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
European Urology Oncology
|
May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer
Antje Neeb, Ines Figueiredo, Bora Gurel, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
The Journal of Clinical Investigation
|
October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp, Ilsa Coleman, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumors
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
Cancers
|
June 2, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
Rebeca Lozano, David Lorente, Isabel M Aragon, et al.
Cell
|
June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Page
of 43
Search research articles
Search
Showing results (321-330 of 426) with videos related to
Sort By:
Page
of 43
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
European Urology Oncology
|
May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 31, 2023
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer
Antje Neeb, Ines Figueiredo, Bora Gurel, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
The Journal of Clinical Investigation
|
October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp, Ilsa Coleman, Wei Yuan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumors
Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
Cancers
|
June 2, 2021
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
Rebeca Lozano, David Lorente, Isabel M Aragon, et al.
Cell
|
June 16, 2018
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, et al.
Page
of 43